Understanding the mechanisms underlying the induction of immunity in the gastrointestinal
mucosa following oral immunization and the cross‐talk between mucosal and systemic …

Despite the availability of advances in molecular diagnostic testing for infectious disease,
there is still a need for tools that advance clinical care and public health. Current methods …

Objectives Studies on serological responses following coronavirus disease-2019 (COVID-
19) have been published primarily in individuals who are moderately or severely …

Background Despite recent progress in understanding the molecular basis of Vibrio
cholerae pathogenesis, there is relatively little knowledge of the factors that determine the …

Serum samples collected from 68 patients (age, mean±the standard deviation [SD],
56.3±12.8 years) at admission who were subsequently molecularly diagnosed as having …

The gram-negative bacterium Vibrio cholerae releases outer membrane vesicles (OMVs)
during growth. In this study, we immunized female mice by the intranasal, intragastric, or …

Background. Diarrheal illnesses remain a leading cause of morbidity and mortality globally,
with increasing recognition of long-term sequelae, including postinfectious irritable bowel …

BACKGROUND: Safety and immunogenicity study of an oral, killed, bivalent whole-cell,
cholera vaccine, Shanchol was carried out in Bangladeshi participants. This study was …

Cholera, caused by Vibrio cholerae, is a noninvasive dehydrating enteric disease with a
high mortality rate if untreated. Infection with V. cholerae elicits long-term protection against …

The safety and immunogenicity of the second generation oral enterotoxigenic Escherichia
coli (ETEC) vaccine ETVAX, consisting of inactivated recombinant E. coli strains over …